可卡因使用障碍患者外周BDNF与proBDNF水平升高:神经营养因子动态研究
本研究为病例对照研究,纳入28名接受治疗的可卡因使用障碍(CUD)患者和38名匹配健康对照,通过酶联免疫吸附法测定外周神经营养因子浓度。结果显示CUD患者BDNF和proBDNF水平均显著高于健康对照,且线性回归模型支持神经营养因子水平与CUD的关联;但两组proBDNF/BDNF比值无显著差异。研究提示BDNF和proBDNF升高可能驱动渴求与复发风险。
要点
- CUD患者外周BDNF和proBDNF水平均显著高于健康对照。
- 两组proBDNF/BDNF比值无显著差异。
- 精神药物使用、精神科住院史和精神科诊断影响神经营养因子动态。
核心结论
- 可卡因使用障碍患者外周BDNF和proBDNF浓度升高,可能参与渴求与复发风险。
研究设计与样本
- 病例对照研究,纳入28名接受治疗的可卡因使用障碍患者和38名匹配健康对照,采用酶联免疫吸附法测定外周神经营养因子浓度。
主要发现
- CUD患者BDNF浓度为18092.80 ± 6844.62 pg/ml,健康对照为11334.42 ± 5061.85 pg/ml,p < 0.001。
- CUD患者proBDNF浓度为87.03 ± 33.23 ng/ml,健康对照为55.70 ± 23.26 ng/ml,p < 0.001。
- 线性回归模型支持神经营养因子水平与CUD的关联。
- 两组proBDNF与BDNF比值无显著差异。
- 精神药物使用、精神科住院史和精神科诊断影响神经营养因子动态。
临床怎么用
- 可关注BDNF和proBDNF作为CUD患者渴求与复发风险的潜在生物标志物,但尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Brain-derived neurotrophic factor (BDNF) and its precursor, proBDNF, are known to significantly contribute to brain homeostasis, neuroplasticity, and neuronal remodeling. Although these neurotrophins are thought to have opposing roles, both play a critical part in shaping long-lasting behavioral changes following substance use. In this context, our study sought to explore the implications of these neurotrophins in the pathophysiology of cocaine use disorder (CUD). We conducted a case-control study, which included 28 individuals seeking treatment for CUD and 38 matched healthy participants. We measured peripheral neurotrophin concentrations via an enzyme-linked immunosorbent assay. Additionally, all participants were screened for cocaine-associated pathways (e.g., cocaine intake, craving intensity), along with associated psychopathological data. Our findings highlighted an increased concentration of BDNF and proBDNF in CUD individuals when compared to healthy controls (BDNF: 18092.80 ± 6844.62 vs. 11334.42 ± 5061.85 pg/ml, p < 0.001; proBDNF: 87.03 ± 33.23 vs. 55.70 ± 23.26 ng/ml, p < 0.001). We further corroborated the relationship between neurotrophin levels and CUD using a linear regression model. Nevertheless, there was no significant difference in the proBDNF to BDNF ratio between the two groups. Interestingly, our study also demonstrated the influence of factors like usage of psychotropic medications, history of psychiatric hospitalizations, and psychiatric diagnoses on neurotrophin dynamics. In conclusion, our study underscores the significance of neurotrophin fluctuations in CUD. The observed increase in BDNF and proBDNF levels could play a pivotal role in driving craving and relapse risk. Thus, a nuanced understanding of these neurobiological underpinnings in CUD might contribute to the development of more targeted and effective therapeutic strategies.
引用
- Pettorruso M, Miuli A, Clemente K, et al. Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorder. Mol Psychiatry. 2024. PMID: 38177347. doi:10.1038/s41380-023-02367-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。